Entering text into the input field will update the search result below

FDA lists four new drugs mentioned in Paragraph IV ANDAs

  • The FDA is out with a list of four new drug products for which the Office of Generic Drugs has received an ANDA containing a Paragraph IV patent certification, meaning the filer contends that a patent listed in the Orange Book either is invalid or unenforceable or will not be infringed by a proposed generic product.
  • The newly listed drugs: Teva's (NYSE:TEVA) Treanda, Bausch & Lomb's (VRX) Bepreve and Prolensa, and Forest Labs' (NYSE:FRX) Namenda XR.
  • FDA release with link to full .pdf list

Recommended For You

More Trending News

About TEVA Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
TEVA--
Teva Pharmaceutical Industries Limited